Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Rating) – Analysts at Oppenheimer dropped their FY2022 earnings per share (EPS) estimates for Crescent Capital BDC in a report issued on Tuesday, May 10th. Oppenheimer analyst M. Penn now expects that the company will post earnings per share of $1.62 for the year, down from their previous forecast of $1.64.
Other equities analysts also recently issued research reports about the stock. Bank of America initiated coverage on shares of Crescent Capital BDC in a research note on Monday, January 31st. They issued a “buy” rating and a $19.50 target price for the company. Zacks Investment Research cut shares of Crescent Capital BDC from a “hold” rating to a “sell” rating in a research note on Tuesday, April 26th. Finally, Wells Fargo & Company reduced their price objective on shares of Crescent Capital BDC from $19.50 to $18.50 and set an “overweight” rating for the company in a research note on Monday, April 25th. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Crescent Capital BDC presently has a consensus rating of “Hold” and an average target price of $19.70.
Crescent Capital BDC (NASDAQ:CCAP – Get Rating) last announced its quarterly earnings data on Wednesday, February 23rd. The company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.41 by $0.01. The business had revenue of $24.14 million for the quarter, compared to analyst estimates of $24.24 million. Crescent Capital BDC had a net margin of 88.98% and a return on equity of 8.03%.
Large investors have recently added to or reduced their stakes in the company. Captrust Financial Advisors purchased a new stake in shares of Crescent Capital BDC in the 3rd quarter worth about $103,000. JPMorgan Chase & Co. purchased a new stake in Crescent Capital BDC during the 1st quarter valued at about $185,000. LPL Financial LLC purchased a new stake in Crescent Capital BDC during the 4th quarter valued at about $190,000. Comerica Bank purchased a new stake in Crescent Capital BDC during the 3rd quarter valued at about $215,000. Finally, Eagle Global Advisors LLC purchased a new stake in Crescent Capital BDC during the 4th quarter valued at about $222,000. 54.76% of the stock is currently owned by hedge funds and other institutional investors.
In other Crescent Capital BDC news, Director Raymond Barrios acquired 2,875 shares of the stock in a transaction dated Tuesday, March 1st. The stock was purchased at an average cost of $17.43 per share, for a total transaction of $50,111.25. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 1.08% of the company’s stock.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 15th. Stockholders of record on Thursday, June 30th will be issued a $0.41 dividend. The ex-dividend date of this dividend is Wednesday, June 29th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 9.64%. Crescent Capital BDC’s payout ratio is 55.78%.
About Crescent Capital BDC (Get Rating)
Crescent Capital BDC, Inc is a business development company. The fund focuses on originating and investing in the debt of middle market companies. It typically focuses on companies based in United States.
- Get a free copy of the StockNews.com research report on Crescent Capital BDC (CCAP)
- Corning Stock is a Technology Value Play
- Wolverine Worldwide Is Ready To Rebound
- Anheuser-Busch InBev May Need One More Quarter to Confirm a Buy Signal
- Wendy’s Growth Story Has Come To An End
- Beyond Meat Could Sizzle After Q1 Results Are Released
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.